Papadopoulos, Nicolas http://orcid.org/0000-0001-7869-862X
Nédélec, Audrey
Derenne, Allison
Şulea, Teodor Asvadur
Pecquet, Christian http://orcid.org/0000-0002-8623-3483
Chachoua, Ilyas
Vertenoeil, Gaëlle
Tilmant, Thomas
Petrescu, Andrei-Jose
Mazzucchelli, Gabriel http://orcid.org/0000-0002-8757-8133
Iorga, Bogdan I. http://orcid.org/0000-0003-0392-1350
Vertommen, Didier http://orcid.org/0000-0001-7648-8282
Constantinescu, Stefan N. http://orcid.org/0000-0002-8599-2699
Funding for this research was provided by:
Fonds De La Recherche Scientifique - FNRS (ASP/A876)
Ludwig Institute for Cancer Research
Article History
Received: 11 May 2022
Accepted: 4 March 2023
First Online: 5 April 2023
Competing interests
: S.N.C. is co-founder of MyeloPro Diagnostics and Research GmbH, Vienna. S.N.C., N.P. and A.N. are co-inventors of a patent application related to the use of inhibitors of the TpoR-mutant CALR interaction (patent application no EP22166303.2). The remaining authors declare no conflict of interests.